Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FEUL
Credit Suisse FI Enhanced Europe 50 Exchange Traded Notes due May 11, 2028 Linked to the STOXX Europ
FEUL
|
+$302M |
| 2 |
FFEU
Barclays ETN+ FI Enhanced Europe 50 ETN Series C
FFEU
|
+$273M |
| 3 |
Petrobras
PBR
|
+$272M |
| 4 |
BHP
BHP
|
+$266M |
| 5 |
Freeport-McMoran
FCX
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$460M |
| 2 |
FIEU
FI Enhanced Europe 50 ETN
FIEU
|
+$267M |
| 3 |
FLEU
Barclays ETN+ FI Enhanced Europe 50 ETN Series B
FLEU
|
+$239M |
| 4 |
HDFC Bank
HDB
|
+$227M |
| 5 |
Comcast
CMCSA
|
+$227M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.36% |
| 2 | Technology | 15.02% |
| 3 | Healthcare | 11.86% |
| 4 | Consumer Discretionary | 9.2% |
| 5 | Consumer Staples | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Toro Company
TTC
$8.72B
| $97.6M | 0.13% |
1,619,829
-4,873
| -0.3% | -$294K |
|
102
West Pharmaceutical
WST
$23.9B
| $96.8M | 0.13% |
975,204
-9,047
| -0.9% | -$833K |
|
103
Morgan Stanley
MS
$330B
| $95.4M | 0.12% |
2,013,397
-53,842
| -3% | -$2.81M |
|
104
Lincoln Electric
LECO
$13.7B
| $94.7M | 0.12% |
1,078,866
+2,780
| +0.3% | +$248K |
|
105
Lennar Class A
LEN
$20.2B
| $94M | 0.12% |
1,849,711
-18,465
| -1% | -$967K |
|
106
Boston Beer
SAM
$1.93B
| $93.6M | 0.12% |
312,289
-1,708
| -0.5% | -$416K |
|
107
Capital One
COF
$129B
| $93.1M | 0.12% |
1,013,124
-17,832
| -2% | -$1.69M |
|
108
Pool Corp
POOL
$6.95B
| $93M | 0.12% |
613,592
-3,399
| -0.6% | -$499K |
|
|
VRNT
109
DELISTED
Verint Systems
VRNT
| $92.9M | 0.12% |
4,111,788
-52,161
| -1% | -$1.13M |
|
110
KB Home
KBH
$3.45B
| $91M | 0.12% |
3,341,963
-17,317
| -0.5% | -$466K |
|
111
NETSCOUT
NTCT
$2.91B
| $86.5M | 0.11% |
2,911,533
-36,828
| -1% | -$1.02M |
|
112
Boeing
BA
$175B
| $81.2M | 0.11% |
241,885
+3,736
| +2% | +$1.29M |
|
113
Pegasystems
PEGA
$4.94B
| $81M | 0.11% |
2,956,762
-65,230
| -2% | -$2M |
|
|
UMPQ
114
DELISTED
Umpqua Holdings Corp
UMPQ
| $81M | 0.11% |
3,583,804
-134,233
| -4% | -$3.14M |
|
115
Invesco QQQ Trust
QQQ
$450B
| $80.3M | 0.1% |
467,648
+31,436
| +7% | +$5.27M |
|
|
BECN
116
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $78.7M | 0.1% |
1,847,197
+64,900
| +4% | +$2.99M |
|
117
Smith & Nephew
SNN
$13.6B
| $78.5M | 0.1% |
2,091,664
+3,602
| +0.2% | +$134K |
|
|
SEM
118
DELISTED
Select Medical
SEM
| $77.4M | 0.1% |
7,917,895
-23,305
| -0.3% | -$229K |
|
119
First American
FAF
$7.71B
| $77.2M | 0.1% |
1,493,226
-13,548
| -0.9% | -$722K |
|
120
Ingredion
INGR
$6.33B
| $77.1M | 0.1% |
696,390
-905
| -0.1% | -$106K |
|
121
Integer Holdings
ITGR
$3.42B
| $77.1M | 0.1% |
1,192,318
-12,104
| -1% | -$751K |
|
122
Qorvo
QRVO
$8.01B
| $76.4M | 0.1% |
952,721
-16,271
| -2% | -$1.26M |
|
123
Bio-Rad Laboratories Class A
BIO
$8.74B
| $75.8M | 0.1% |
262,697
-2,375
| -0.9% | -$656K |
|
124
Helen of Troy
HELE
$649M
| $75.6M | 0.1% |
768,372
-1,610
| -0.2% | -$147K |
|
|
AAWW
125
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $75.3M | 0.1% |
1,050,037
-9,522
| -0.9% | -$643K |
|
Similar funds
Ken Fisher's Q2 2018 Portfolio in Review
As of Q2 2018, Ken Fisher held 924 positions worth $77B, up 2.1% from $75.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Ken Fisher's Q2 2018 filing shows 95 new, 298 increased, 389 reduced and 62 closed positions. Its largest new stake was Credit Suisse FI Enhanced Europe 50 Exchange Traded Notes due May 11, 2028 Linked to the STOXX Europ: 3,218,864 shares worth $294M. The largest sale was Amazon, an estimated $460M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- Ken Fisher's largest Q2 2018 buy was Credit Suisse FI Enhanced Europe 50 Exchange Traded Notes due May 11, 2028 Linked to the STOXX Europ: 3,218,864 shares worth $294M.
- Ken Fisher added most to Barclays ETN+ FI Enhanced Europe 50 ETN Series C in Q2 2018, an estimated $273M increase.
- Ken Fisher's biggest Q2 2018 reduction was Amazon, cutting an estimated $460M.
- Ken Fisher fully exited Dr. Reddy's Laboratories in Q2 2018, selling an estimated $165M.
- Ken Fisher's ten largest holdings make up 26% of its $77B portfolio in Q2 2018.
- Ken Fisher opened 95 new positions and closed 62 in Q2 2018.
- Ken Fisher's portfolio value rose 2.1% quarter-over-quarter to $77B.
Based on Fisher Asset Management's 13F filing for Q2 2018, filed 9 Jul 2018.